These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8617583)

  • 21. Phase I evaluation of diaziquone in childhood cancer. A Pediatric Oncology Group study.
    Falletta JM; Cushing B; Lauer S; Bell B; Mahoney DH; Castleberry R; Krance RA
    Invest New Drugs; 1990 May; 8(2):167-70. PubMed ID: 2384303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous-infusion diaziquone in acute myeloid leukemia: a Southeastern Cancer Study Group trial.
    Lyman GH; Vogler WR; Raney M
    Cancer Treat Rep; 1987 Mar; 71(3):309-10. PubMed ID: 3545462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diaziquone (AZQ).
    Bender JF; Grillo-Lopez AJ; Posada JG
    Invest New Drugs; 1983; 1(1):71-84. PubMed ID: 6381377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive phase II evaluation of aziridinylbenzoquinone (AZQ, diaziquone) in recurrent human primary brain tumors.
    Eagan RT; Dinapoli RP; Cascino TL; Scheithauer B; O'Neill BP; O'Fallon JR
    J Neurooncol; 1987; 5(4):309-14. PubMed ID: 3440875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of metastatic breast cancer with AZQ: a phase II trial.
    Martino S; Ratanatharathorn V; Samal BA; Singhakowinta A; Haas C
    Cancer Invest; 1988; 6(3):289-91. PubMed ID: 3167612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase II study of diaziquone in children with recurrent or progressive solid tumors. Report from the Childrens Cancer Study Group.
    Ettinger LJ; Ru N; Krailo MD; Ruccione KS; Krivit WA; Hammond GD
    Am J Pediatr Hematol Oncol; 1990; 12(3):301-5. PubMed ID: 2240475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I trial of granulocyte-macrophage colony-stimulating factor plus high-dose cyclophosphamide given every 2 weeks: a Cancer and Leukemia Group B study.
    Lichtman SM; Ratain MJ; Van Echo DA; Rosner G; Egorin MJ; Budman DR; Vogelzang NJ; Norton L; Schilsky RL
    J Natl Cancer Inst; 1993 Aug; 85(16):1319-26. PubMed ID: 8340944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diaziquone given as a continuous infusion is an active agent for relapsed adult acute nonlymphocytic leukemia.
    Lee EJ; Van Echo DA; Egorin MJ; Nayar MS; Shulman P; Schiffer CA
    Blood; 1986 Jan; 67(1):182-7. PubMed ID: 3940546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases.
    Anderson PM; Markovic SN; Sloan JA; Clawson ML; Wylam M; Arndt CA; Smithson WA; Burch P; Gornet M; Rahman E
    Clin Cancer Res; 1999 Sep; 5(9):2316-23. PubMed ID: 10499599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II study of diaziquone in untreated advanced gastric carcinoma. A Southwest Oncology Group Study.
    Pugh RP; Fleming T; Guy JT; Weick JK; Ward JH
    Am J Clin Oncol; 1989 Feb; 12(1):11-3. PubMed ID: 2912017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase I/II study of 24 hour intravenous AZQ in recurrent primary brain tumors.
    Chamberlain MC; Prados MD; Silver P; Levin VA
    J Neurooncol; 1988 Dec; 6(4):319-23. PubMed ID: 3221259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.
    de Gast GC; Klümpen HJ; Vyth-Dreese FA; Kersten MJ; Verra NC; Sein J; Batchelor D; Nooijen WJ; Schornagel JH
    Clin Cancer Res; 2000 Apr; 6(4):1267-72. PubMed ID: 10778950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative pharmacokinetics of single-dose administration of mammalian and bacterially-derived recombinant human granulocyte-macrophage colony-stimulating factor.
    Hovgaard D; Mortensen BT; Schifter S; Nissen NI
    Eur J Haematol; 1993 Jan; 50(1):32-6. PubMed ID: 8436212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I-II diaziquone chemotherapy in brain tumors.
    Madajewicz S; Spaulding M; Bhimani S; Avellanosa A; DeLos Santos R; Perry A; Zeigler P; Kirshner J
    Cancer Treat Rep; 1984 Jun; 68(6):913-4. PubMed ID: 6733706
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetics of diaziquone after three different dosage regimens.
    Bjornsson TD; Schold SC; Friedman HS; Schneider D; Falletta JM
    Cancer Treat Rep; 1985 Dec; 69(12):1383-5. PubMed ID: 4075314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory small cell carcinoma of the lung.
    Fuks JZ; Aisner J; Van Echo DA; Levitt M; Ihde DC; Carney D; Wiernik PH
    Am J Clin Oncol; 1983 Apr; 6(2):171-3. PubMed ID: 6299094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium.
    Halperin EC; Gaspar L; Imperato J; Salter M; Herndon J; Dowling S
    Am J Clin Oncol; 1993 Aug; 16(4):277-83. PubMed ID: 8392285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AZQ therapy in patients with disseminated malignant melanoma.
    Yap BS; Bedikian AY; Burgess MA; Bodey GP
    Am J Clin Oncol; 1982 Dec; 5(6):623-5. PubMed ID: 7165003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II clinical evaluation of AZQ in colorectal cancer.
    Bedikian AY; Stroehlein JR; Karlin DA; Korinek J; Bodey GP
    Am J Clin Oncol; 1982 Oct; 5(5):535-7. PubMed ID: 7180831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ability of a new antitumor agent, AZQ, to penetrate into cerebrospinal fluid.
    Gormley PE; Wood JH; Poplack DG
    Pharmacology; 1981; 22(3):196-8. PubMed ID: 7208602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.